To include your compound in the COVID-19 Resource Center, submit it here.

Befar (Alprox-TD): Completed Phase II study

NexMed Inc. (NEXM), Robbinsville, N.J.
Product: Befar ( Alprox-TD)

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE